Diabetic retinopathy: Treatment

Speakers: Philip Burgess, John Wilding

Speaker bios | Disclosures

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss the treatment of sight-threatening retinopathy and maculopathy in people with diabetes (9:11).

Learning points

• The impact of laser treatment on VEGF production in the peripheral retina.
• Recent evidence demonstrating the efficacy of anti-VEGF monoclonal antibodies  delivered via intravitreal injection.
• The key treatment benefits and drawbacks for choosing injection therapy versus laser therapy
• The approaches being investigated to minimize the treatment burden and drawbacks associated with multiple anti-VEGF monoclonal antibody injections and laser treatment.
• New approaches being investigated including, endothelial progenitor cell based therapy.

More videos in this series

• Diabetic retinopathy: Screening.
• Diabetic retinopathy: Pathogenesis.
• Diabetic retinopathy: Treatment.